ストックスクリーナーアプリを入手
297.69
1.89%
5.53
アフターアワーズ：
298.00
0.31
+0.10%
Alnylam Pharmaceuticals Inc (ALNY) 最新ニュース
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts - Yahoo Finance
Alnylam to collaborate with Inceptive to use AI for RNAi therapy development - MSN
Alnylam Slides as Investors Refocus on Near-term Amvuttra Growth After Recent AI-deal Headlines - Moomoo
Bloom Energy, Astera Labs, Alnylam, Reddit could be among next adds to S&P 500 - MSN
Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500 - Barron's
City banks nearly $100M for next-gen RNAi drugs - BioPharma Dive
Alnylam slides as investors refocus on near-term Amvuttra growth after recent AI-deal headlines - Quiver Quantitative
Regeneron: 'Buy' Revenue Growth And Two Extensive Drug Development Opportunities - Seeking Alpha
The week in pharma: action, reaction and insight – week to June 5, 2026 - The Pharma Letter
How a US$2 Billion Generative AI RNAi Deal At Alnylam Pharmaceuticals (ALNY) Has Changed Its Investment Story - simplywall.st
H.C. Wainwright reiterates Alnylam stock Buy rating at $510 By Investing.com - Investing.com Canada
Alnylam Pharmaceuticals (ALNY) Valuation Check As US$2b AI RNAi Collaboration With Inceptive Nucleics Gains Attention - Yahoo Finance
Alnylam Pharmaceuticals (ALNY) Partners with Inceptive Nucleics to Enhance Drug Discovery - GuruFocus
ALNY Reiterated by HC Wainwright & Co. -- Maintains Price Target at $510 - GuruFocus
Ionis, Alnylam, BioMarin up as Citi starts at buy on catalyst and growth outlook - MSN
H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $510 - Moomoo
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion - Benzinga
Alnylam, Inceptive ink AI deal potentially worth $2B - BioPharma Dive
Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development - Yahoo Finance
Alnylam, Inceptive Sign AI-RNAi Drug Discovery Deal Worth Up To $2bn - Citeline News & Insights
ATTR treatment landscape heats up as clinical progress gathers pace - The Pharma Letter
AI Collaboration Puts Alnylam’s RNAi Pipeline Productivity In Focus - simplywall.st
Alnylam signs $2 billion AI pact with Inceptive - The Pharma Letter
Alnylam (ALNY) Partners with Inceptive Nucleics for $2B Innovati - GuruFocus
Alnylam stock rises on $2B AI drug discovery partnership - Investing.com
Alnylam (ALNY) Partners with Inceptive Nucleics for $2B Innovation Deal - GuruFocus
Alnylam Pharmaceuticals (ALNY) Partners with Inceptive Nucleics for AI-Driven RNAi Development - GuruFocus
Alnylam and Inceptive Form Strategic AI Collaboration to Acceler - GuruFocus
Alnylam director Pyott sells $1.15m in stock By Investing.com - Investing.com Australia
Alnylam stock rises on $2B AI drug discovery partnership By Investing.com - Investing.com Nigeria
Alnylam director Pyott sells $1.15m in stock - Investing.com
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics - 01net
Alnylam, Inceptive sign up to $2 billion AI drug discovery deal - Reuters
Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics - statnews.com
Alnylam (ALNY) director sells 3,830 shares after expiring option exercise - Stock Titan
Alnylam Pharmaceuticals (ALNY) director receives 4,393 stock options grant - Stock Titan
Benjamin Cravatt joins ALNYLAM PHARMACEUTICALS (ALNY) board and files Form 3 - Stock Titan
Alnylam Pharmaceuticals stock hits 52-week low at $283.58 By Investing.com - Investing.com India
Homozygous Familial Hypercholesterolemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 – DelveInsight | Arrowhead Pharma, Novartis, Alnylam Pharma, LIB Therapeutics - Barchart.com
Alnylam Pharmaceuticals stock hits 52-week low at $283.58 - Investing.com
Alnylam Pharmaceuticals (ALNY): Company Profile, Stock Price, News, Rankings - Fortune
Avoiding Lag: Real-Time Signals in (ALNY) Movement - Stock Traders Daily
ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) - ChartMill
[144] ALNYLAM PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Are options traders betting on a big move in Alnylam stock? - MSN
Alnylam Pharmaceuticals (NASDAQ:ALNY) Shows Strong Alignment with the Little Book That Makes You Rich Growth Strategy - ChartMill
Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Powerhouse with 47.63% Potential Upside - DirectorsTalk Interviews
Are Options Traders Betting on a Big Move in Alnylam Stock? - TradingView
ALNY News | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) - ChartMill
How Investors May Respond To Alnylam Pharmaceuticals (ALNY) Adding Scientific Depth Amid RNAi Pipeline Scrutiny - simplywall.st
0.71%
0.97%
大文字化:
|
ボリューム (24 時間):